Seifert R - Search Results

1

Prostate Cancer Theranostics: PSMA Targeted Therapy.

Seifert R, Alberts IL, Afshar-Oromieh A, Rahbar K. Seifert R, et al. PET Clin. 2021 Jul;16(3):391-396. doi: 10.1016/j.cpet.2021.03.004. PET Clin. 2021. PMID: 34053583 Review.

2

Diagnostic performance of ¹⁸F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer.

Rahbar K, Afshar-Oromieh A, Seifert R, Wagner S, Schäfers M, Bögemann M, Weckesser M. Rahbar K, et al. Among authors: seifert r. Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2055-2061. doi: 10.1007/s00259-018-4089-x. Epub 2018 Jul 20. Eur J Nucl Med Mol Imaging. 2018. PMID: 30027419 Free PMC article.

3

[¹⁷⁷Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer.

Rahbar K, Ahmadzadehfar H, Seifert R, Boegemann M. Rahbar K, et al. Among authors: seifert r. Lancet Oncol. 2018 Aug;19(8):e371. doi: 10.1016/S1470-2045(18)30410-8. Lancet Oncol. 2018. PMID: 30102221 No abstract available.

4

Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007.

Seifert R, Schafigh D, Bögemann M, Weckesser M, Rahbar K. Seifert R, et al. Clin Nucl Med. 2019 Jun;44(6):e394-e395. doi: 10.1097/RLU.0000000000002543. Clin Nucl Med. 2019. PMID: 30889005

5

FDG-PET proves to be reliable in the diagnostic workup of a rare cardiac hemangioma.

Seifert R, Schafigh D, Hoffmeier A, Huss S, Weckesser M, Rahbar K. Seifert R, et al. J Card Surg. 2019 Oct;34(10):1097-1099. doi: 10.1111/jocs.14197. Epub 2019 Aug 2. J Card Surg. 2019. PMID: 31374577

6

Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving ¹⁷⁷Lu-PSMA-617.

Kessel K, Seifert R, Schäfers M, Weckesser M, Schlack K, Boegemann M, Rahbar K. Kessel K, et al. Among authors: seifert r. Theranostics. 2019 Jul 9;9(17):4841-4848. doi: 10.7150/thno.35759. eCollection 2019. Theranostics. 2019. PMID: 31410185 Free PMC article.

7

Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy.

Seifert R, Kessel K, Boegemann M, Köhler M, Roll W, Stegger L, Weckesser M, Rahbar K. Seifert R, et al. J Nucl Med. 2020 May;61(5):723-728. doi: 10.2967/jnumed.119.233429. Epub 2019 Oct 10. J Nucl Med. 2020. PMID: 31601703 Free article.

8

Radioligand therapy using [¹⁷⁷Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis.

Seifert R, Kessel K, Schlack K, Weckesser M, Bögemann M, Rahbar K. Seifert R, et al. Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2106-2112. doi: 10.1007/s00259-020-04703-3. Epub 2020 Feb 16. Eur J Nucl Med Mol Imaging. 2020. PMID: 32062682 Free PMC article.

9

Incremental diagnostic value of [¹⁸F]tetrafluoroborate PET-CT compared to [¹³¹I]iodine scintigraphy in recurrent differentiated thyroid cancer.

Dittmann M, Gonzalez Carvalho JM, Rahbar K, Schäfers M, Claesener M, Riemann B, Seifert R. Dittmann M, et al. Among authors: seifert r. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2639-2646. doi: 10.1007/s00259-020-04727-9. Epub 2020 Apr 4. Eur J Nucl Med Mol Imaging. 2020. PMID: 32248325 Free PMC article.

10

Semiautomatically Quantified Tumor Volume Using ⁶⁸Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer.

Seifert R, Herrmann K, Kleesiek J, Schäfers M, Shah V, Xu Z, Chabin G, Grbic S, Spottiswoode B, Rahbar K. Seifert R, et al. J Nucl Med. 2020 Dec;61(12):1786-1792. doi: 10.2967/jnumed.120.242057. Epub 2020 Apr 24. J Nucl Med. 2020. PMID: 32332147 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

790 results

Search Page

Filters